Changes in Significant Shareholders
|
|
February 9, 2007, Osaka, Japan ---- Santen Pharmaceutical Co., Ltd. announced
the changes in significant shareholders as of February 2, 2007. |
|
| 1. |
Details of the change
On February 8, 2007, Silchester International Investors Limited filed a fund's report to the Kanto Local Finance Bureau relating to changes in significant shareholders as follows. |
|
| 2. |
Description of Shareholder Company |
| (1) Name of shareholder |
Silchester International Investors Limited |
| (2) Address |
Time and Life Bldg. 5th floor, 1 Bruton Street, London, W1J 6TL |
| (3) Representative |
Stephen Butt, Chairman |
| (4) Description of business |
Asset Management Company |
|
| 3. |
Number and Percentage of Voting Rights Owned by the Company |
|
|
Voting rights owned by the Company |
Percentage of outstanding shares |
Shareholder ranking |
Before
(as of September 30, 2006) |
88,084
(8,808,400 shares) |
10.17% |
1st |
After
(as of February 1, 2007) |
78,972
(7,897,200 shares) |
9.12% |
1st |
|
|
|
| Note1. |
Outstanding shares were 86,781,203 as of September 30, 2006. Deducted non voting shares from total outstanding shares were 162,403. |
| Note2. |
Above numbers are based on the significant shareholdings report filed by the company and they are not confirmed real shareholding numbers. |
|
|
| 4. |
Outlook for the future |
| Nothing in particular |
|
|
|
Back to top
|
|
|
|
